These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29021931)
21. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining. Tropsha A; Zheng W Curr Pharm Des; 2001 May; 7(7):599-612. PubMed ID: 11375770 [TBL] [Abstract][Full Text] [Related]
22. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents. Ahmadi S; Habibpour E Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182 [TBL] [Abstract][Full Text] [Related]
23. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study. Gupta A; Kumar V; Aparoy P Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847 [TBL] [Abstract][Full Text] [Related]
24. Testing non-additivity of biological activity in a combinatorial library. Nanxiang G; Cho SJ; Hermsmeier M; Poss M; Shen CF Comb Chem High Throughput Screen; 2002 Mar; 5(2):147-54. PubMed ID: 11966423 [TBL] [Abstract][Full Text] [Related]
25. A QSAR study using MTD method and Dragon descriptors for a series of selective ligands of α2C adrenoceptor. Borota A; Mracec M; Gruia A; Rad-Curpăn R; Ostopovici-Halip L; Mracec M Eur J Med Chem; 2011 Mar; 46(3):877-84. PubMed ID: 21277656 [TBL] [Abstract][Full Text] [Related]
26. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors. Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392 [TBL] [Abstract][Full Text] [Related]
27. QSAR modeling, docking and ADMET studies for exploration of potential anti-malarial compounds against Plasmodium falciparum. Qidwai T In Silico Pharmacol; 2016 Dec; 5(1):6. PubMed ID: 28726171 [TBL] [Abstract][Full Text] [Related]
28. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations. Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912 [TBL] [Abstract][Full Text] [Related]
29. Antidepressant Drug Design on TCAs and Phenoxyphenylpropylamines Utilizing QSAR and Pharmacophore Modeling. Kumar A; Nandi S; Saxena AK Comb Chem High Throughput Screen; 2022; 25(3):451-461. PubMed ID: 32875980 [TBL] [Abstract][Full Text] [Related]
30. QSAR study about ATP-sensitive potassium channel activation of cromakalim analogues using CP-MLR approach. Sharma S; Prabhakar YS; Singh P; Sharma BK Eur J Med Chem; 2008 Nov; 43(11):2354-60. PubMed ID: 18353509 [TBL] [Abstract][Full Text] [Related]
31. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies. Sharma MC Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391 [TBL] [Abstract][Full Text] [Related]
32. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation. Al-Nadaf AH; Taha MO J Mol Graph Model; 2011 Apr; 29(6):843-64. PubMed ID: 21376648 [TBL] [Abstract][Full Text] [Related]
33. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools. Roy K; Mandal AS J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745 [TBL] [Abstract][Full Text] [Related]
34. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities. Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160 [TBL] [Abstract][Full Text] [Related]
35. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling. Aboalhaija NH; Zihlif MA; Taha MO Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606 [TBL] [Abstract][Full Text] [Related]
36. QSAR and molecular docking studies of lethal factor protease inhibitors against Saxena M; Nandi S; Saxena AK SAR QSAR Environ Res; 2019 Oct; 30(10):715-731. PubMed ID: 31556709 [No Abstract] [Full Text] [Related]
38. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity. Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104 [TBL] [Abstract][Full Text] [Related]
39. Application of QSAR Method in the Design of Enhanced Antimalarial Derivatives of Azetidine-2-carbonitriles, their Molecular Docking, Drug-likeness, and SwissADME Properties. Ibrahim ZY; Uzairu A; Shallangwa GA; Abechi SE Iran J Pharm Res; 2021; 20(3):254-270. PubMed ID: 34903987 [TBL] [Abstract][Full Text] [Related]
40. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F. Wang XS; Tang H; Golbraikh A; Tropsha A J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]